CALT Calliditas Therapeutics
- 19.501
- +0.051+0.26%
Calliditas Therapeutics News
Stifel Nicolaus Sticks to Its Buy Rating for Calliditas Therapeutics (CALT)
European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Thursday Trading
European equities traded in the US as American depositary receipts were trending modestly higher Thursday morning, rising 0.24% to 1,364.10 on the S&P Europe Select ADR Index. From continental Europe,
Calliditas Therapeutics' 2023 Annual Report Published
Calliditas Therapeutics AB (NASDAQ: CALT), (NASDAQ STOCKHOLM: CALTX) ("Calliditas") today announces that the Annual Report for 2023 now is available...
Calliditas Therapeutics Says OLE Study Shows Treatment Response Consistent With Late-Stage NefIgArd Study's Findings
Calliditas Therapeutics (CALT) said Wednesday that an open-label extension, or OLE, study to its late-stage NefIgArd study showed a treatment response that was consistent with the NefIgArd study's fin
Calliditas Announces Positive NefIgArd Open Label Extension Results
STOCKHOLM, April 24, 2024 /PRNewswire/ -- Calliditas Therapeutics AB (NASDAQ: CALT), (NASDAQ STOCKHOLM: CALTX) ("Calliditas") today announced that the global open-label extension (OLE) study to the P
European Equities Traded in the US as American Depositary Receipts Rebound in Monday Trading
After closing out last week more than 2% lower, European equities traded in the US as American depositary receipts rebounded Monday morning, rising 1.09% to 1,340.58 on the S&P Europe Select ADR Index
European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading But End Week Down
European equities traded in the US as American depositary receipts were trending higher Friday morning, rising 0.46% to 1,330.20 on the S&P Europe Select ADR Index. Despite the gain, the index remains
Express News | Calliditas Therapeutics Presents Additional Data Analyses From Phase 3 NeflgArd Trial Of Nefecon In Primary IgA Nephropathy At ISN World Congress Of Nephrology 2024
European Equities Traded in the US as American Depositary Receipts Start Week Higher in Monday Trading
European equities traded in the US as American depositary receipts kicked off the week trending moderately higher Monday morning, rising 0.53% to 1,352.74 on the S&P Europe Select ADR Index. From cont
European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading
European equities traded in the US as American depositary receipts were lower Friday morning, falling 0.66% to 1,356.48 on the S&P Europe Select ADR Index. The index is poised to close the week down n
European Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading
European equities traded in the US as American depositary receipts were weaker Thursday morning, falling 0.91% to 1,353.49 on the S&P Europe Select ADR Index.
Buy Rating Affirmed for Calliditas Therapeutics Amid Positive Market Trends and Upcoming Catalysts
European Equities Traded in the US as American Depositary Receipts Trend Lower in Wednesday Trading
European equities traded in the US as American depositary receipts were trending lower during Wednesday morning's session, falling 0.9% to 1,365.87 on the S&P Europe Select ADR Index. From continental
European Equities Traded in the US as American Depositary Receipts Trend Lower in Tuesday Trading
European equities traded in the US as American depositary receipts were trending moderately lower Tuesday morning, declining 0.49% to 1,372.87 on the S&P Europe Select ADR Index. From continental Euro
Calliditas Therapeutics to Attend Conferences in April
STOCKHOLM, April 9, 2024 /PRNewswire/ -- Calliditas Therapeutics AB (Nasdaq: CALT, Nasdaq Stockholm: CALTX) ("Calliditas"), a commercial biopharma company focused on rare diseases today announced tha
Express News | Calliditas Therapeutics To Present Nefecon Data At ISN World Congress Of Nephrology
Calliditas Receives Notice of Allowance for United States Patent Application Covering Setanaxib in Cancer Treatment
Calliditas Therapeutics AB (NASDAQ: CALT) (NASDAQ Stockholm: CALTX) ("Calliditas") today announced that the Company has received a Notice of...
European Equities Traded in the US as American Depositary Receipts Higher in Friday Trading, Close Out Week Lower
European equities traded in the US as American depositary receipts were trending modestly higher Friday morning, rising 0.27% to 1,369.92 on the S&P Europe Select ADR Index. However, the gain isn't en
European Equities Traded in the US as American Depositary Receipts Trend Higher in Thursday Trading
European equities traded in the US as American depositary receipts were trending higher Thursday morning, rising 0.69% to 1,386.14 on the S&P Europe Select ADR Index. From continental Europe, the gain
Analysts Offer Insights on Healthcare Companies: Calliditas Therapeutics (CALT), AK Medical Holdings Ltd. (HK:1789) and Consun Pharmaceutical Group Ltd. (Frankfurt: DE:C1P)
Analysis
Price Target
No Data
